151 related articles for article (PubMed ID: 21497279)
1. Increased risks of upper tract urothelial carcinoma in male and female chinese herbalists.
Yang HY; Wang JD; Lo TC; Chen PC
J Formos Med Assoc; 2011 Mar; 110(3):161-8. PubMed ID: 21497279
[TBL] [Abstract][Full Text] [Related]
2. Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists.
Yang HY; Wang JD; Lo TC; Chen PC
J Epidemiol; 2009; 19(1):17-23. PubMed ID: 19164871
[TBL] [Abstract][Full Text] [Related]
3. Response to "Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists".
Su YR; Chen CH
J Formos Med Assoc; 2013 Aug; 112(8):501. PubMed ID: 23664667
[No Abstract] [Full Text] [Related]
4. Author response to "Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists".
Yang HY; Wang JD; Chen PC
J Formos Med Assoc; 2013 Aug; 112(8):502-3. PubMed ID: 23685084
[No Abstract] [Full Text] [Related]
5. Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists.
Yang HY; Wang JD; Lo TC; Chen PC
J Urol; 2013 Jan; 189(1):48-52. PubMed ID: 23164394
[TBL] [Abstract][Full Text] [Related]
6. Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.
Dickman KG; Chen CH; Grollman AP; Pu YS
World J Urol; 2023 Apr; 41(4):899-907. PubMed ID: 35867141
[TBL] [Abstract][Full Text] [Related]
7. Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001-2018: a national population-based cohort study.
Liao CI; Fang HC; Lee PT; Hsu CY; Chen CL; Huang CW; Chen XY; Ou SH; Tsai CT; Chou KJ
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8201-8211. PubMed ID: 37061628
[TBL] [Abstract][Full Text] [Related]
8. Association of blood lead and mercury with estimated GFR in herbalists after the ban of herbs containing aristolochic acids in Taiwan.
Lin HH; Chou SA; Yang HY; Hwang YH; Kuo CH; Kao TW; Lo TC; Chen PC
Occup Environ Med; 2013 Aug; 70(8):545-51. PubMed ID: 23703822
[TBL] [Abstract][Full Text] [Related]
9. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
Lai MN; Wang SM; Chen PC; Chen YY; Wang JD
J Natl Cancer Inst; 2010 Feb; 102(3):179-86. PubMed ID: 20026811
[TBL] [Abstract][Full Text] [Related]
10. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
[TBL] [Abstract][Full Text] [Related]
11. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan.
Wu MJ; Lian JD; Yang CR; Cheng CH; Chen CH; Lee WC; Shu KH; Tang MJ
Am J Kidney Dis; 2004 Jun; 43(6):1091-7. PubMed ID: 15168390
[TBL] [Abstract][Full Text] [Related]
12. Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids.
Yang HY; Wang JD; Lo TC; Chen PC
Occup Environ Med; 2011 Apr; 68(4):286-90. PubMed ID: 20935286
[TBL] [Abstract][Full Text] [Related]
13. Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients.
Hsiao PJ; Hsieh PF; Chang CH; Wu HC; Yang CR; Huang CP
Ren Fail; 2016 Jun; 38(5):663-70. PubMed ID: 26956094
[TBL] [Abstract][Full Text] [Related]
14. Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis.
Jhuang JR; Chiang CJ; Su SY; Yang YW; Lee WC
Sci Rep; 2019 Dec; 9(1):19860. PubMed ID: 31882686
[TBL] [Abstract][Full Text] [Related]
15. Urinary tuberculosis is associated with the development of urothelial carcinoma but not renal cell carcinoma: a nationwide cohort study in Taiwan.
Lien YC; Wang JY; Lee MC; Shu CC; Chen HY; Hsieh CH; Lee CH; Lee LN; Chao KM
Br J Cancer; 2013 Nov; 109(11):2933-40. PubMed ID: 24129236
[TBL] [Abstract][Full Text] [Related]
16. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.
Grollman AP
Environ Mol Mutagen; 2013 Jan; 54(1):1-7. PubMed ID: 23238808
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.
Wang SM; Lai MN; Wei A; Chen YY; Pu YS; Chen PC; Wang JD
PLoS One; 2014; 9(8):e105218. PubMed ID: 25170766
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of urothelial cancer in young and middle aged patients with end-stage renal disease.
Wang SM; Lai MN; Chen PC; Wang JD
J Formos Med Assoc; 2015 Jan; 114(1):52-7. PubMed ID: 24360022
[TBL] [Abstract][Full Text] [Related]
19. [A Cohort Study on the Prognosis of Patients with Urothelial Carcinoma Using the Miyazaki Urological Cancer Database (MUCD)].
Kimura S; Terada N; Otsuka I; Kimura T; Fujisaki Y; Okabe K; Akioka T; Fujii M; Onizuka C; Yamazaki T; Kuroiwa K; Mukai S; Kamoto T
Hinyokika Kiyo; 2021 Sep; 67(9):407-412. PubMed ID: 34610705
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area.
Chang CW; Ou CH; Yu CC; Lo CW; Tsai CY; Cheng PY; Chen YT; Huang HC; Wu CC; Li CC; Lee HY
BMC Cancer; 2021 Jan; 21(1):80. PubMed ID: 33468084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
